SCHEMBL329520

SCHEMBL329520

CCC(CC)S(=O)(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL128775 0.97 TP53 (0.31)
Hydrochloric Acid SCHEMBL28792672 0.97 TP53 (0.31)
SCHEMBL14955502 0.88 TP53 (0.30)
SCHEMBL28108473 0.87 TP53 (0.35)
SCHEMBL490947 0.85
SCHEMBL1507280 0.83
SCHEMBL4546739 0.83 SLC22A6 (0.37)
SCHEMBL490886 0.83 TP53 (0.32)
SCHEMBL1627316 0.83
SCHEMBL329281 0.83 HDAC1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 286 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118290499-A Preparation method of netilmicin sulfate 福建省福抗药业股份有限公司 2024-07-05 CN claimed
CN-106404736-A Special detection method and equipment for estradiol in duck meat 百奥森(江苏)食品安全科技有限公司 2017-02-15 CN claimed
EP-2610958-B1 Non-aqueous electrolyte and electrochemical device comprising the same LG CHEMICAL LTD (KR) 2014-10-01 EP claimed
CN-101333227-B Method for making alkoxy-modified silsesquioxanes BRIDGESTONE CORP 2013-08-21 CN claimed
EP-2269261-B1 NON-AQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL DEVICE COMPRISING THE SAME LG CHEMICAL LTD (KR) 2013-05-01 EP claimed
CN-101333227-A Method for making alkoxy-modified silsesquioxanes BRIDGESTONE AMERICAS HOLDING I (JP) 2008-12-31 CN claimed
US-20080317834-A1 Compounds and methods for modulating cerebral amyloid angiopathy NEUROCHEM (INTERNATIONAL) LIMITED (CH) 2008-12-25 US claimed
EP-1064013-A4 $i(IN VITRO) FORMATION OF CONGOPHILIC MALTESE-CROSS AMYLOID PLAQUES TO IDENTIFY ANTI-PLAQUE THERAPEUTICS FOR THE TREATMENT OF ALZHEIMER'S AND PRION DISEASES UNIV WASHINGTON (US) 2005-05-11 EP claimed
JP-3623236-B2 2005-02-23 JP claimed
US-20040220138-A1 Methods for modulating neuronal cell death NEUROCHEM (INTERNATIONAL) LIMITED (CH) 2004-11-04 US claimed
US-20020022657-A1 Methods for modulating neuronal cell death NEUROCHEM (INTERNATIONAL) LIMITED (GI) 2002-02-21 US claimed
WO-2001085093-A2 COMPOUNDS AND METHODS FOR MODULATING CEREBRAL AMYLOID ANGIOPATHY NEUROCHEM, INC. (US) 2001-11-15 WO claimed
EP-1077690-A1 USE OF AMYLOID INHIBITORS FOR MODULATING NEURONAL CELL DEATH Neurochem, Inc. (CA) 2001-02-28 EP claimed
EP-1064013-A1 $i(IN VITRO) FORMATION OF CONGOPHILIC MALTESE-CROSS AMYLOID PLAQUES TO IDENTIFY ANTI-PLAQUE THERAPEUTICS FOR THE TREATMENT OF ALZHEIMER'S AND PRION DISEASES University of Washington (US) 2001-01-03 EP claimed
WO-1999045947-A9 IN VITRO FORMATION OF CONGOPHILIC MALTESE-CROSS AMYLOID PLAQUES TO IDENTIFY ANTI-PLAQUE THERAPEUTICS FOR THE TREATMENT OF ALZHEIMER'S AND PRION DISEASES UNIV WASHINGTON (US) 2000-03-02 WO claimed
WO-1999059571-A1 USE OF AMYLOID INHIBITORS FOR MODULATING NEURONAL CELL DEATH NEUROCHEM, INC. (US) 1999-11-25 WO claimed
WO-1999045947-A1 IN VITRO FORMATION OF CONGOPHILIC MALTESE-CROSS AMYLOID PLAQUES TO IDENTIFY ANTI-PLAQUE THERAPEUTICS FOR THE TREATMENT OF ALZHEIMER'S AND PRION DISEASES UNIVERSITY OF WASHINGTON (US) 1999-09-16 WO claimed
US-5840294-A INHIBITING AMYLOID DEPOSITION BY ADMINISTERING A THERAPEUTIC COMPOUND COMPRISING AN ANIONIC GROUP AND A CARRIER MOLECULE QUEEN'S UNIVERSITY AT KINGSTON (CA) 1998-11-24 US claimed
EP-0814842-A1 METHOD FOR TREATING AMYLOIDOSIS Queen's University at Kingston (CA) 1998-01-07 EP claimed
WO-1996028187-A1 METHOD FOR TREATING AMYLOIDOSIS QUEEN'S UNIVERSITY AT KINGSTON (CA) 1996-09-19 WO claimed